Literature DB >> 23150261

Epigenetic regulation of cancer stem cell gene expression.

Sharmila A Bapat1.   

Abstract

The concept of cancer as a stem cell disease has slowly gained ground over the last decade. A 'stem-like' state essentially necessitates that some cells in the developing tumor express the properties of remaining quiescent, self-renewing and regenerating tumors through establishment of aberrant cellular hierarchies. Alternatively, such capacities may also be reacquired through a de-differentiation process. The abnormal cellular differentiation patterns involved during either process during carcinogenesis are likely to be driven through a combination of genetic events and epigenetic regulation. The role(s) of the latter is increasingly being appreciated in acquiring the requisite genomic specificity and flexibility required for phenotypic plasticity, specifically in a context wherein genome sequences are not altered for differentiation to ensue. In this chapter, the recent advances in elucidating epigenetic mechanisms that govern the self-renewal, differentiation and regenerative potentials of cancer stem cells will be presented.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23150261     DOI: 10.1007/978-94-007-4525-4_18

Source DB:  PubMed          Journal:  Subcell Biochem        ISSN: 0306-0225


  4 in total

1.  Panobinostat, a histone deacetylase inhibitor, rescues the angiogenic potential of endothelial colony-forming cells in moyamoya disease.

Authors:  Anshika Jangra; Seung Ah Choi; Eun Jung Koh; Youn Joo Moon; Kyu-Chang Wang; Ji Hoon Phi; Ji Yeoun Lee; Seung-Ki Kim
Journal:  Childs Nerv Syst       Date:  2019-02-27       Impact factor: 1.475

2.  The JAZF1-SUZ12 fusion protein disrupts PRC2 complexes and impairs chromatin repression during human endometrial stromal tumorogenesis.

Authors:  Xianyong Ma; Jinglan Wang; Jianhui Wang; Charles X Ma; Xiaobin Gao; Vytas Patriub; Jeffrey L Sklar
Journal:  Oncotarget       Date:  2017-01-17

3.  Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells.

Authors:  Mengying Tong; Ziqian Deng; Mengying Yang; Chang Xu; Xiaolong Zhang; Qingzheng Zhang; Yuwei Liao; Xiaodi Deng; Dekang Lv; Xuehong Zhang; Yu Zhang; Peiying Li; Luyao Song; Bicheng Wang; Aisha Al-Dherasi; Zhiguang Li; Quentin Liu
Journal:  Cancer Commun (Lond)       Date:  2018-09-19

Review 4.  Novel molecular insights and new therapeutic strategies in osteosarcoma.

Authors:  Babak Otoukesh; Bahram Boddouhi; Mehdi Moghtadaei; Peyman Kaghazian; Maria Kaghazian
Journal:  Cancer Cell Int       Date:  2018-10-16       Impact factor: 5.722

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.